Entry Detail



General Information

Database ID:exR0000106
RNA Name:ABTB2
RNA Type:mRNA
Chromosome:chr11
Starnd:-
Coordinate:
Start Site(bp):34150987End Site(bp):34358010
External Links:ENSG00000166016



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACAA2
chr18
49782164
49813953
-
AL136454.1
chr1
192716132
192716653
+
ATE1
chr10
121740421
121928801
-
CEP104
chr1
3812086
3857214
-
CYP4X1
chr1
47023669
47050751
+
ECE1
chr1
21217247
21345572
-
EEF2
chr19
3976056
3985463
-
FAM118A
chr22
45308968
45341955
+
FASN
chr17
82078338
82098294
-
GAPDH
chr12
6534512
6538374
+
ID3
chr1
23557926
23559501
-
KRAS
chr12
25205246
25250936
-
NPAT
chr11
108157215
108222638
-
PDIA4
chr7
149003062
149028662
-
PHC3
chr3
170086732
170181749
-
PTTG1IP
chr21
44849585
44873903
-
RAB1B
chr11
66268590
66277492
+
RBBP4
chr1
32651142
32686211
+
RPL22
chr1
6185020
6209389
-
RPS18
chr6
33272075
33276511
+
RUSC1
chr1
155320894
155331114
+
SERP1
chr3
150541998
150603228
-
SHISA5
chr3
48467798
48504826
-
SRGN
chr10
69088103
69104805
+
SRP68
chr17
76038775
76072517
-
STAT6
chr12
57095408
57132139
-
TBC1D2B
chr15
77984036
78077724
-
TUBB
chr6
30720352
30725426
+
TWNK
chr10
100987367
100994403
+
ZFYVE9
chr1
52142094
52346686
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AP003392.4
chr11
119065263
119065677
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.